BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bornschein J, Drozdov I, Malfertheiner P. Octreotide LAR: safety and tolerability issues. Expert Opin Drug Saf 2009;8:755-68. [PMID: 19998528 DOI: 10.1517/14740330903379525] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Barracano R, Merola A, Fusco F, Scognamiglio G, Sarubbi B. Protein-losing enteropathy in Fontan circulation: Pathophysiology, outcome and treatment options of a complex condition. International Journal of Cardiology Congenital Heart Disease 2022;7:100322. [DOI: 10.1016/j.ijcchd.2022.100322] [Reference Citation Analysis]
2 Bhatia M, Kavi L, Nelson-piercy C. Postural tachycardia syndrome and pregnancy. Obstet Gynecol 2018;20:119-23. [DOI: 10.1111/tog.12478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zou Z, Yan X, Lu H, Qi X, Gu Y, Li X, Wu B, Qi X. Comparison of drugs facilitating endoscopy for patients with acute variceal bleeding: a systematic review and network meta-analysis. Ann Transl Med 2019;7:717. [PMID: 32042733 DOI: 10.21037/atm.2019.12.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu J, Xu Y, Liu Z, Ren H, Meng Z, Liu K, Liu Z, Yong J, Wang Y, Li X. A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres. European Journal of Pharmaceutics and Biopharmaceutics 2019;144:217-29. [DOI: 10.1016/j.ejpb.2019.09.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
5 Holleran G, Hall B, Breslin N, McNamara D. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial. United European Gastroenterol J. 2016;4:70-76. [PMID: 26966525 DOI: 10.1177/2050640614559121] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
6 Pivonello R, Muscogiuri G, Holder G, Paul M, Sarp S, Lesogor A, Jordaan P, Eisinger J, Colao A. Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies. Endocrine 2018;60:65-72. [PMID: 29116540 DOI: 10.1007/s12020-017-1448-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Stevens P, Burden S, Delicata R, Carlson G, Lal S; Cochrane IBD Group. Somatostatin analogues for treatment of enterocutaneous fistula. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010489] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Satapathy S, Mittal BR, Sood A, Sood A, Kapoor R, Gupta R, Khosla D. 177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors: A Single-Institution Experience. JCO Glob Oncol 2021;7:1167-75. [PMID: 34288699 DOI: 10.1200/GO.21.00103] [Reference Citation Analysis]
9 Stevens P, Foulkes RE, Hartford-Beynon JS, Delicata RJ. Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula. Eur J Gastroenterol Hepatol 2011;23:912-22. [PMID: 21814141 DOI: 10.1097/MEG.0b013e32834a345d] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
10 Gezer E, Demirhan Y, Selek A, Cantürk Z, Çetinarslan B, Sözen M, Köksalan D, Karatoprak AP. Comparison between somatostatin analog injections. Rev Assoc Med Bras 2022;68:514-8. [DOI: 10.1590/1806-9282.20211224] [Reference Citation Analysis]
11 Kogawa K, Ando T, Fujiwara M. Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report. Cardiol Young 2021;:1-3. [PMID: 33588957 DOI: 10.1017/S1047951121000391] [Reference Citation Analysis]
12 Pavel M, Valle JW, Eriksson B, Rinke A, Caplin M, Chen J, Costa F, Falkerby J, Fazio N, Gorbounova V, de Herder W, Kulke M, Lombard-Bohas C, O'Connor J, Sorbye H, Garcia-Carbonero R; Antibes Consensus Conference Participants; Antibes Consensus Conference participants. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 2017;105:266-280. [PMID: 28351033 DOI: 10.1159/000471880] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 14.4] [Reference Citation Analysis]
13 Motivala S, Gologorsky Y, Kostandinov J, Post KD. Pituitary Disorders During Pregnancy. Endocrinology and Metabolism Clinics of North America 2011;40:827-36. [DOI: 10.1016/j.ecl.2011.08.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
14 Öberg K, Lamberts SW. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer 2016;23:R551-66. [PMID: 27697899 DOI: 10.1530/ERC-16-0151] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
15 Prencipe N, Bona C, Cuboni D, Parasiliti-Caprino M, Berton AM, Fenoglio LM, Gasco V, Ghigo E, Grottoli S. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 2021;24:242-51. [PMID: 33164134 DOI: 10.1007/s11102-020-01102-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Meoni G, Giommoni E, Petreni P, Pillozzi S, Mazzoni F, Pellegrini E, Brugia M, Lunghi A, Muto A, Antonuzzo L. Somatostatin analogs in pregnant patients with neuroendocrine tumor. Anti-Cancer Drugs 2020;31:1096-8. [DOI: 10.1097/cad.0000000000000967] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Martelli L, Colard A, Fontaine F, Deflandre J, Bastens B, Louis E. Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea. Scand J Gastroenterol 2017;52:564-9. [PMID: 28270045 DOI: 10.1080/00365521.2017.1284893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
18 Sun X, Tang S, Hou B, Duan Z, Liu Z, Li Y, He S, Wang Q, Chang Q. Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension. BMC Gastroenterol 2021;21:2. [PMID: 33407159 DOI: 10.1186/s12876-020-01532-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 O’meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-vergani G. Successful Use of Long-Acting Octreotide for Intractable Chronic Gastrointestinal Bleeding in Children. Journal of Pediatric Gastroenterology & Nutrition 2015;60:48-53. [DOI: 10.1097/mpg.0000000000000540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
20 VanderPluym J. Cluster Headache: Special Considerations for Treatment of Female Patients of Reproductive Age and Pediatric Patients. Curr Neurol Neurosci Rep 2016;16:5. [PMID: 26711274 DOI: 10.1007/s11910-015-0610-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Montella L, Ottaviano M, Morra R, Pietroluongo E, De Placido P, Tortora M, Sorrentino C, Facchini G, De Placido S, Giuliano M, Palmieri G. The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug? Cancers (Basel) 2022;14:774. [PMID: 35159040 DOI: 10.3390/cancers14030774] [Reference Citation Analysis]
22 Dickler MN. Targeting the Insulin-Like Growth Factor Pathway in Estrogen Receptor–Positive Breast Cancer: A Bumpy Start With an Uncertain Future. JCO 2011;29:3846-8. [DOI: 10.1200/jco.2011.36.6393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
23 Nakayama G, Morioka D, Murakami T, Takakura H, Miura Y, Togo S. Chylous ascites occurring after low anterior resection of the rectum successfully treated with an oral fat-free elemental diet (Elental(®)). Clin J Gastroenterol 2012;5:216-9. [PMID: 22773935 DOI: 10.1007/s12328-012-0304-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gallaher JR, Charles A. Acute Cholecystitis: A Review. JAMA 2022;327:965-75. [PMID: 35258527 DOI: 10.1001/jama.2022.2350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chan MM, Chan MM, Mengshol JA, Fish DN, Chan ED. Octreotide. Chest 2013;144:1937-45. [DOI: 10.1378/chest.13-0382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cui PJ, Yao J, Zhu Y, Zhang ZY, Yang J. Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension. Gastroenterol Res Pract 2017;2017:3943210. [PMID: 28855918 DOI: 10.1155/2017/3943210] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Loos JA, Negro P, Cumino AC. In vitro anti-echinococcal activity of octreotide: Additive effect of metformin linked to autophagy. Acta Trop 2020;203:105312. [PMID: 31870710 DOI: 10.1016/j.actatropica.2019.105312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Skajaa GO, Mathiesen ER, Iyore E, Beck-Nielsen H, Jimenez-Solem E, Damm P. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report. BMC Res Notes 2014;7:804. [PMID: 25404386 DOI: 10.1186/1756-0500-7-804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]